ARDT · NYSE · CIK 0001756655

Ardent Health, Inc.

Ardent Health, Inc.’s most recent SEC filing in our snapshot is a Form 8-K filed on Oct 23, 2026. In fiscal 2025 (year ended Dec 31, 2025) it reported revenue of $6.3B and net income of $135.8M, according to its XBRL data on EDGAR. Its EDGAR record lists 26 Form 4 insider filings from the 12 months before our last refresh.

SEC EDGAR snapshot updated Oct 27, 2026, 11:27 PM EDT. See all filings on sec.gov.

Revenue, FY2025
$6.3B
Net income, FY2025
$135.8M
Form 4 filings on record, past 12 months
26

Company overview

Legal name (as filed)
Ardent Health, Inc.
Ticker
ARDT
SEC Central Index Key (CIK)
0001756655
Business address
BRENTWOOD, TN
State or country of incorporation
DE
Fiscal year ends
December 31
SEC filer category
Accelerated filer
Position in SEC ticker list
#2077 of the 3,000 companies we track

Five-year financial highlights

Full-year figures from Ardent Health, Inc.’s annual reports, as tagged in XBRL and published by the SEC. Amounts are in U.S. dollars; the fiscal year is named for the calendar year in which it ends.

Revenue
$5.1BFY2022$5.4BFY2023$6.0BFY2024$6.3BFY2025
Net income
$188.9MFY2022$53.9MFY2023$210.3MFY2024$135.8MFY2025
ARDT annual results
ItemFY2022
ended Dec 31, 2022
FY2023
ended Dec 31, 2023
FY2024
ended Dec 31, 2024
FY2025
ended Dec 31, 2025
Revenue$5.1B$5.4B$6.0B$6.3B
Net income$188.9M$53.9M$210.3M$135.8M
Diluted EPS$1.50$0.43$1.58$0.96
Total assets—$4.7B$5.0B$5.3B
Cash and equivalents$456.1M$437.6M$556.8M$709.6M

XBRL tags used: revenue = Revenues; netIncome = NetIncomeLoss; assets = Assets; eps = EarningsPerShareDiluted; cash = CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents. EPS is shown as originally reported for each year and may not be adjusted for later stock splits. A dash means the company did not report that item in a form we could match.

How to read these numbers

Revenue is the money a company brings in from selling its products and services; net income is what is left after all expenses, interest and taxes. Diluted EPS spreads net income across every share that could exist if options and convertible securities were exercised. Total assets and cash are balance-sheet figures measured on the last day of the fiscal year. For the full story — segment results, one-time charges, guidance — read Management’s Discussion and Analysis in the Form 10-K.

Latest key reports

The most recent filing of each major report type, even if it falls outside the 40 newest filings below.

ARDT latest annual, quarterly, current and proxy reports
FiledFormWhat it isOriginal
Mar 16, 202610-KAnnual report· period Dec 31, 2025Document · Index
Aug 10, 202610-QQuarterly report· period Jun 30, 2026Document · Index
Oct 23, 20268-KDirector or officer change· period Oct 19, 2026Document · Index
Apr 8, 2026DEF 14ADefinitive proxy statement· period May 20, 2026Document · Index

Recent SEC filings

The 40 newest documents filed by or about Ardent Health, Inc., by form type:

4 ×228-K ×8144 ×410-Q ×2ARS ×1DEFA14A ×1DEF 14A ×110-K ×1
ARDT recent filings
FiledFormWhat it isOriginal
Oct 23, 20268-KDirector or officer change· period Oct 19, 2026Document · Index
Sep 29, 20264Statement of changes in beneficial ownership (insider trade)· period Sep 25, 2026Document · Index
Sep 29, 20264Statement of changes in beneficial ownership (insider trade)· period Sep 25, 2026Document · Index
Sep 29, 20264Statement of changes in beneficial ownership (insider trade)· period Sep 25, 2026Document · Index
Sep 4, 20268-KOther events· period Sep 4, 2026Document · Index
Aug 27, 2026144Notice of proposed sale of securitiesDocument · Index
Aug 25, 2026144Notice of proposed sale of securitiesDocument · Index
Aug 20, 2026144Notice of proposed sale of securitiesDocument · Index
Aug 18, 2026144Notice of proposed sale of securitiesDocument · Index
Aug 10, 202610-QQuarterly report· period Jun 30, 2026Document · Index
Aug 4, 20268-KResults of operations· period Aug 4, 2026Document · Index
Jul 2, 20264Statement of changes in beneficial ownership (insider trade)· period Jul 1, 2026Document · Index
Jun 30, 20268-KDirector or officer change· period Jun 26, 2026Document · Index
Jun 8, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 5, 2026Document · Index
Jun 8, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 5, 2026Document · Index
Jun 2, 20268-KDirector or officer change; Regulation FD disclosure· period Jun 2, 2026Document · Index
May 26, 20268-KShareholder vote results· period May 20, 2026Document · Index
May 6, 202610-QQuarterly report· period Mar 31, 2026Document · Index
May 5, 20268-KResults of operations· period May 5, 2026Document · Index
Apr 8, 2026ARSARS· period Dec 31, 2025Document · Index
Apr 8, 2026DEFA14AAdditional proxy soliciting materialsDocument · Index
Apr 8, 2026DEF 14ADefinitive proxy statement· period May 20, 2026Document · Index
Apr 2, 20264Statement of changes in beneficial ownership (insider trade)· period Apr 1, 2026Document · Index
Apr 2, 20264Statement of changes in beneficial ownership (insider trade)· period Apr 1, 2026Document · Index
Apr 2, 20264Statement of changes in beneficial ownership (insider trade)· period Apr 1, 2026Document · Index
Apr 2, 20264Statement of changes in beneficial ownership (insider trade)· period Apr 1, 2026Document · Index
Apr 2, 20264Statement of changes in beneficial ownership (insider trade)· period Apr 1, 2026Document · Index
Apr 2, 20264Statement of changes in beneficial ownership (insider trade)· period Apr 1, 2026Document · Index
Apr 2, 20264Statement of changes in beneficial ownership (insider trade)· period Apr 1, 2026Document · Index
Apr 2, 20264Statement of changes in beneficial ownership (insider trade)· period Apr 1, 2026Document · Index
Apr 2, 20264Statement of changes in beneficial ownership (insider trade)· period Apr 1, 2026Document · Index
Apr 2, 20264Statement of changes in beneficial ownership (insider trade)· period Apr 1, 2026Document · Index
Apr 2, 20264Statement of changes in beneficial ownership (insider trade)· period Apr 1, 2026Document · Index
Apr 2, 20264Statement of changes in beneficial ownership (insider trade)· period Mar 31, 2026Document · Index
Apr 2, 20264Statement of changes in beneficial ownership (insider trade)· period Mar 31, 2026Document · Index
Apr 2, 20264Statement of changes in beneficial ownership (insider trade)· period Mar 31, 2026Document · Index
Apr 2, 20264Statement of changes in beneficial ownership (insider trade)· period Mar 31, 2026Document · Index
Mar 27, 20268-KDirector or officer change· period Mar 24, 2026Document · Index
Mar 16, 202610-KAnnual report· period Dec 31, 2025Document · Index
Mar 13, 20264Statement of changes in beneficial ownership (insider trade)· period Mar 11, 2026Document · Index

Insider filing activity

26 Form 4 filings appear in Ardent Health, Inc.’s EDGAR record between Oct 28, 2025 and our last refresh. Most are reports by the company’s own directors, officers and 10% owners, but EDGAR also lists a Form 4 under a company when the company itself is the insider — for example, when it owns more than 10% of another public company. Foreign private issuers’ own insiders generally do not file Form 4. A high count is not by itself a signal: many Form 4s report routine stock awards, tax withholding or sales under pre-arranged Rule 10b5-1 plans. Open each filing to see the transaction code, share count and price. What a Form 4 shows.

Other companies in Services-General Medical & Surgical Hospitals, NEC

All 5 companies in Services-General Medical & Surgical Hospitals, NEC· Companies headquartered in Tennessee

On Amazon

Popular tools for investors

As an Amazon Associate I earn from qualifying purchases.

Source

  • U.S. Securities and Exchange Commission, EDGAR submissions for CIK 0001756655 and XBRL company facts. Ardent Health, Inc. on EDGAR.
  • Snapshot updated Oct 27, 2026, 11:27 PM EDT. The SEC does not endorse OpenFilings. Company names and tickers are used only to identify the filer; no logos are shown.

Not investment advice. This page summarizes public SEC filings for information only. Figures may contain errors or omissions; confirm everything in the original filing before relying on it.